Results 241 to 250 of about 14,728,452 (289)
Some of the next articles are maybe not open access.
Plasmin activates VEGF-C and VEGF-D
International Congress Series, 2004Abstract Angiogenesis and lymphangiogenesis (growth of lymphatic vessels) are guided by members of the vascular endothelial growth factor (VEGF) family of secreted glycoproteins. In particular, VEGF-C and VEGF-D promote lymphangiogenesis as demonstrated in transgenic animal models and gene delivery studies.
Bradley K McColl +6 more
openaire +1 more source
Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer
International Journal of Clinical Oncology, 2005The molecular mechanisms of lymphangiogenesis induced by vascular endothelial growth factor (VEGF)-C and VEGF-D in gastric cancer were studied.VEGF-C and VEGF-D gene expression vectors were transfected into the gastric cancer cell line KKLS, which did not originally express VEGF-C and VEGF-D, and stable transfectants (KKLS/VEGF-C and KKLS/VEGF-D) were ...
Yutaka, Yonemura +7 more
openaire +2 more sources
Diagnostic value of serum VEGF-D in consecutive patients with lymphangioleiomyomatosis
European Respiratory Journal, 2011Background: Serum levels of vascular endothelial growth factor-D (VEGF-D) are increased in patients with lymphangioleiomyomatosis (LAM). Objective: To explore the value of measurement of serum level of VEGF-D for the diagnosis of LAM.
Vincent Cottin +11 more
openaire +1 more source
Serum level of VEGF-D in patients with primary lymphedema.
Lymphology, 2005Recent studies have indicated that vascular endothelial growth factor-D (VEGF-D) stimulates lymphangiogenesis in humans. Furthermore, mutations of vascular endothelial growth factor receptor 3 (VEGFR-3) have been observed in families with hereditary lymphedema. The lack of stimulation of lymphangiogenesis could lead to production of even more VEGF-D to
A M, Fink +5 more
openaire +1 more source
PROTEOLYTIC ACTIVATION OF VEGF-C AND VEGF-D
Cardiovascular Pathology, 2004Bradley McColl +5 more
openaire +1 more source
Treatment of Renal Cell Carcinoma: Current Status and Future Directions
Ca-A Cancer Journal for Clinicians, 2017Pedro Coelho Barata
exaly
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Cancer Cell, 2017Jonas Bergh +2 more
exaly
Adverse Effects of Anticancer Agents That Target the VEGF Pathway
Nature Reviews Clinical Oncology, 2009Helen X Chen
exaly

